CD274 and cancer: GBs (and other cancer cells) overexpress programmed cell death ligand 1 (PD-L1) which, upon interaction with PD-1, inhibits T cell proliferation and the T cell receptor (TCR)-dependent IL-2 production and suppresses the CD4+ and CD8+ response [657].